When was Launch Therapeutics founded?

Launch Therapeutics was founded in 2022.

Where is Launch Therapeutics located?

Launch Therapeutics is headquartered in Boston, United States.

Who is the current CEO of Launch Therapeutics?

Anshul Thakral of Launch Therapeutics.

How many employees does Launch Therapeutics have?

As of Apr 30, 2026, the latest employee count at Launch Therapeutics is 31.

Is Launch Therapeutics a funded company?

Launch Therapeutics is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does Launch Therapeutics rank among its competitors?

Launch Therapeutics ranks 11th amongst 47 active competitors, of which 4 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Hikinger Pharmaceutical Technology, which secured an undisclosed amount in Apr, 2020.

Who are the top competitors of Launch Therapeutics?

Launch Therapeutics' top competitors include United BioSource Corporation, Hikinger Pharmaceutical Technology and River Vision Development. Among them, Hikinger Pharmaceutical Technology secured the most recent funding round in April, 2020.

Launch Therapeutics - 2026 Company Profile, Team, Funding & Competitors

Launch Therapeutics is a funded company based in Boston (United States), founded in 2022. It operates as a Provider of late stage clinical development services for biopharma sector. The company has 47 active competitors, including 4 funded and 3 that have exited. Its top competitors include companies like United BioSource Corporation, Hikinger Pharmaceutical Technology and River Vision Development.

Company Details

Website: launchtx.com
Email ID: *****@launchtx.com

Key Metrics

Founded Year

2022

Location

Boston, United States

Stage

Funding Raised

Investors

Abingworth

Ranked

11^th among 47 active competitors

Employee Count

31 as on Apr 30, 2026

Similar Companies

United BioSource Corporation & 55 more

View Launch Therapeutics' full profile

Launch Therapeutics is a funded company. Launch Therapeutics has 1 institutional investor.

View details of Launch Therapeutics's funding rounds and investors

Launch Therapeutics' employee count trend

Launch Therapeutics has 31 employees as of Apr 26. Here is Launch Therapeutics's employee count trend over the years:

Employee count trend for Launch Therapeutics

Uncover Launch Therapeutics' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Launch Therapeutics include United BioSource Corporation, Hikinger Pharmaceutical Technology and River Vision Development. Here is the list of Top 10 competitors of Launch Therapeutics, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	United BioSource Corporation 2003, Blue Bell (United States), Acquired	Uniting evidence and access to improve patient outcomes for biopharma	$278M	New Enterprise Associates, Oak HC/FT & 9 others	60/100
2nd	Hikinger Pharmaceutical Technology 2006, Beijing (China), Series B	Provider of phase I-IV drug research and development services	-	Sigma Square Capital	28/100
3rd	River Vision Development 2011, Series A	Provider of late stage clinical development services	$17M	Lundbeck Foundation, SR One & 1 others	28/100
4th	Concentrics Research 1999, Indianapolis (United States), Acquired	Late-stage (Phase II-IV trials) CRO	-	-	26/100
5th	Clinexa 2008, Hyderabad (India), Unfunded	Indian CRO offering comprehensive clinical research and site-management services for for phase II - IV clinical studies	-	-	26/100
6th	Ipsum 2014, Medellin (Colombia), Seed	CRO helping life sciences companies by setting-up and managing clinical trials	$200K	GITP Ventures	26/100
7th	US Biotest 2000, San Luis Obispo (United States), Funding Raised	Provider of late-stage clinical trials studies for multiple therapeutic diseases	-	Military Health, HHS	25/100
8th	Ray 2010, Giza (Egypt), Unfunded	Provider of online airport parking space booking and management services	-	-	24/100
9th	O4 Research 2009, Belfast (United Kingdom), Unfunded	Manufacturer of conductive metal-clad fibers for diverse applications	-	-	24/100
10th	Nexus Biosciences 2012, Carlsbad (United States), Funding Raised	CRO specializing in late stage, observational and post-approval studies	-	Telegraph Hill Partners	23/100
11th	Launch Therapeutics 2022, Boston (United States), Funding Raised	Provider of late stage clinical development services for biopharma sector	-	Abingworth	23/100